NEOADAURA is a randomized, controlled, phase III trial that randomized 351 patients with resectable stage II-IIIB non-small-cell lung cancer (NSCLC; exon 19 del or exon 21 point mutations) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback